Maps
Partnership

Leveraging the Multidisciplinary Association for Psychedelic Studies’ (MAPS) protocol, this unique experiential training opportunity allows practitioners to deepen their understanding of MDMA-Assisted Therapy.

PSYCHEDELIC EXPERIENTIAL OPPORTUNITIES FOR MDMA-ASSISTED THERAPY

Numinus has submitted a Clinical Trial Application (CTA) to Health Canada to enable MDMA-Assisted Therapy Experiential Opportunities for practitioners as part of an investigational Phase 1 clinical trial.

If approved, Numinus intends to make the Experiential Opportunity available to practitioners as part of its psychedelic-assisted therapy education and training program.

HOW YOU CAN GET INVOLVED

Practitioners who complete our MDMA-Assisted Therapy education program, or have already completed previous MDMA-Assisted Therapy training and are qualified to enroll in our Practical Applications course, would be able to apply to participate in the experiential clinical trial - enabling them to observe, deliver, and receive the therapeutic protocol as part of their training experience. Sign up for our mailing list below to be notified when applications open.

BE THE FIRST TO KNOW

Stay up to date on MDMA-Assisted Therapy
opportunities and our partnership with MAPS.

Training Interest Form - US

First Name(Required)
First Name(Required)
Questions?
Call us toll-free 1-833-NUMINUS (686-4687)
crosschevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram